Mode
Text Size
Log in / Sign up

HLA-DPA1 and HLA-DPB1 expression is downregulated in pediatric asthma with high diagnostic valueNew guideline reveals molecular changes in pediatric asthma cells

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note downregulated HLA-DPA1/DPB1 expression in pediatric asthma with high diagnostic value.

This guideline presents a multi-level integrated transcriptomic analysis focused on pediatric asthma patients. The scope covers molecular mechanisms including HLA-DPA1 and HLA-DPB1 expression, antigen presentation, and metabolic dysfunction within the disease context.

The analysis indicates that HLA-DPA1 and HLA-DPB1 expression is significantly downregulated in pediatric asthma samples. Diagnostic value is described as high. Additionally, antigen presentation is attenuated while metabolic dysfunction is enhanced. In IL-13-treated bronchial epithelial cells and patient samples, reduced mRNA and protein expression of HLA-DPA1 and HLA-DPB1 is observed.

Macrophage subclustering reveals that HLA-DPA1 and HLA-DPB1 are enriched in the Macro2 subset, which is characterized by metabolic and stress-related functions. Pseudotime trajectory analysis shows a shift from immune-activated toward metabolically stressed states. Cell-cell communication identifies epithelial cells as primary signal senders, macrophages and dendritic cells as central receivers, and the MIF signaling axis as a key intercellular bridge.

The authors note that direct functional validation is required to establish causality. This guideline lays a foundation for potential molecular targets for future precision therapeutic strategies. No adverse events or safety data are reported.

Children with asthma often struggle with breathing issues that standard treatments do not fully fix. A new guideline looks deep into the biology of these conditions to find new clues. It found that specific genes in immune cells are turned down in kids with asthma. These cells also show signs of being stressed and struggling to function properly. The study looked at how these cells talk to each other and how they handle energy. It found that the cells sending signals are different from the ones receiving them in these patients. This shift suggests the immune system is working in a unique way for these children. The research also noted that these cells have trouble handling metabolic demands. This means they might be burning through energy too fast or not getting enough. Understanding these changes is important because it could lead to better ways to help these kids breathe easier.

What this means for you:
This guideline highlights specific cell changes in pediatric asthma that could guide future treatments.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedJun 2026
View Original Abstract ↓
Pediatric asthma (PA) is a prevalent chronic respiratory disease. Emerging evidence suggests that dysregulated macrophage heterogeneity and immune-metabolic crosstalk contribute to disease pathogenesis, yet specific molecular nodes linking innate immune dysfunction to PA remain unidentified. This study aimed to identify and characterize immune checkpoint-related candidate key genes in PA. Bulk RNA-sequencing data from airway epithelium of PA patients (training set GSE152004) were analyzed for differential expression, followed by intersection with immune checkpoint-related genes. Four machine learning algorithms (SVM−RFE, Boruta, LASSO, and XGBoost) were applied to screen candidate key genes, which were further validated in an independent dataset (GSE65204). A nomogram was constructed to evaluate diagnostic value. Functional enrichment, immune infiltration, and regulatory network analyses were performed. In vitro IL-13 stimulation of bronchial epithelial cells and patient peripheral blood mononuclear cell samples were used for experimental validation. Single-cell RNA-seq data (GSE254127) were analyzed for cell typing, macrophage subclustering, pseudotime trajectory, and cell−cell communication. HLA-DPA1 and HLA-DPB1 were identified as candidate key genes by consensus of all four algorithms. Both were significantly downregulated in PA and showed high diagnostic value (nomogram). Downregulation of HLA-DPA1/DPB1 correlated with attenuated antigen presentation and enhanced metabolic dysfunction. IL-13-treated bronchial epithelial cells and patient samples confirmed reduced mRNA and protein expression. Exploratory single-cell analysis revealed that HLA−DPA1/DPB1 were enriched in macrophages, specifically a Macro2 subset characterized by metabolic and stress-related functions—highlighting macrophage heterogeneity in innate immune regulation. Pseudotime trajectory suggested a shift from immune-activated toward metabolically stressed states. Cell−cell communication analysis identified epithelial cells as primary signal senders, with macrophages and dendritic cells as central receivers, and the MIF signaling axis as a key intercellular bridge. This multi-level integrated transcriptomic analysis identified HLA-DPA1 and HLA-DPB1 as candidate key genes in childhood asthma, and reveals their potential role in immune-metabolic dysregulation centered on macrophage functional heterogeneity. Our data are consistent with a potential role for these genes in immune-metabolic dysregulation centered on macrophage functional heterogeneity, although direct functional validation is required to establish causality. These findings provide new insights into innate immune circuits in childhood asthma and lay a foundation for potential molecular targets for future precision therapeutic strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.